NCT02768077View on ClinicalTrials.gov

Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease

PHASE4UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Parkinson's Disease
Interventions
DRUG

Melatonin(Circadin®)

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Kuhnil Pharmaceutical Co., Ltd.

INDUSTRY

NCT02768077 - Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease | Biotech Hunter | Biotech Hunter